DK2068891T3 - Sammensætning omfattende krebsdyr gastrolith komponenter, calciumcarbonat og anvendelse deraf - Google Patents

Sammensætning omfattende krebsdyr gastrolith komponenter, calciumcarbonat og anvendelse deraf

Info

Publication number
DK2068891T3
DK2068891T3 DK07827185.5T DK07827185T DK2068891T3 DK 2068891 T3 DK2068891 T3 DK 2068891T3 DK 07827185 T DK07827185 T DK 07827185T DK 2068891 T3 DK2068891 T3 DK 2068891T3
Authority
DK
Denmark
Prior art keywords
composition
calcium carbonate
components
crustacean gastrolith
crustacean
Prior art date
Application number
DK07827185.5T
Other languages
English (en)
Inventor
Yossi Ben
Amir Sagi
Original Assignee
Univ Ben Gurion
Yossi Ben
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Ben Gurion, Yossi Ben filed Critical Univ Ben Gurion
Application granted granted Critical
Publication of DK2068891T3 publication Critical patent/DK2068891T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A61K33/10—Carbonates; Bicarbonates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716—Glucans
    • A61K31/722—Chitin, chitosan
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/56—Materials from animals other than mammals
    • A61K35/60—Fish, e.g. seahorses; Fish eggs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Rheumatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Inorganic Chemistry (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Cardiology (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pain & Pain Management (AREA)
  • Psychology (AREA)
  • Nutrition Science (AREA)
  • Oncology (AREA)
  • Hospice & Palliative Care (AREA)
  • Urology & Nephrology (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Psychiatry (AREA)
  • Pulmonology (AREA)
  • Vascular Medicine (AREA)
  • Immunology (AREA)
DK07827185.5T 2006-10-05 2007-10-07 Sammensætning omfattende krebsdyr gastrolith komponenter, calciumcarbonat og anvendelse deraf DK2068891T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IL178495A IL178495A (en) 2006-10-05 2006-10-05 Use of cancerous gastric components or artificial calcium containing carbonate, chitin and polypeptide preparations to treat calcium metabolism-related or calcium-signaling conditions
PCT/IL2007/001211 WO2008041236A2 (en) 2006-10-05 2007-10-07 Composition comprising crustacean gastrolith components, calcium carbonate and its use

Publications (1)

Publication Number Publication Date
DK2068891T3 true DK2068891T3 (da) 2014-01-13

Family

ID=39153987

Family Applications (1)

Application Number Title Priority Date Filing Date
DK07827185.5T DK2068891T3 (da) 2006-10-05 2007-10-07 Sammensætning omfattende krebsdyr gastrolith komponenter, calciumcarbonat og anvendelse deraf

Country Status (14)

Country Link
US (2) US20100098774A1 (da)
EP (1) EP2068891B1 (da)
JP (1) JP2010505818A (da)
CN (1) CN101563091A (da)
AU (1) AU2007303786B2 (da)
CA (1) CA2665141C (da)
CY (1) CY1114930T1 (da)
DK (1) DK2068891T3 (da)
ES (1) ES2439741T3 (da)
IL (1) IL178495A (da)
PL (1) PL2068891T3 (da)
PT (1) PT2068891E (da)
SI (1) SI2068891T1 (da)
WO (1) WO2008041236A2 (da)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8257750B2 (en) * 1999-04-30 2012-09-04 Kibow Biotech, Inc. Calcium carbonate compositions for preventing or treating hyperphosphatemia
EP2251018B1 (en) 2007-10-22 2014-12-17 Amorphical Ltd. Stable amorphous calcium carbonate comprising phosphorylated amino acids, synthetic phosphorylated peptides, and gastrolith proteins
WO2013088440A1 (en) * 2011-12-13 2013-06-20 Amorphical Ltd. Amorphous calcium carbonate for the treatment of calcium malabsorption and metabolic bone disorders
BR112015002505B1 (pt) 2012-08-07 2021-07-20 Amorphical Ltd. Método para preparar carbonato de cálcio amorfo(acc), suspensão de acc estabilizada, pó de acc estável e uso de uma suspensão ou pó
CN105007925A (zh) * 2013-02-11 2015-10-28 艾玛菲克有限公司 用于加速骨生长的无定形碳酸钙
CN103417635B (zh) * 2013-08-15 2015-05-20 张荣惠 接骨药
US11602542B2 (en) 2014-07-31 2023-03-14 Amorphical Ltd. Non-aqueous liquid and semi-solid formulations of amorphous calcium carbonate
IL256065B2 (en) 2015-06-04 2024-04-01 Amorphical Ltd Amorphous calcium carbonate stabilized by polyphosphates or bisphosphonates
US12121538B2 (en) 2015-06-04 2024-10-22 Amorphical Ltd. Compositions of amorphous calcium carbonate for inhalation, sublingual or buccal administration
PT3389407T (pt) * 2015-12-14 2024-01-19 Nestle Sa Composição nutricional e fórmula para lactentes para promover mielinização de novo
WO2017102719A1 (en) * 2015-12-14 2017-06-22 Nestec S.A. Nutritional compositions and infant formulas to promote myelination in the brain
US11478011B2 (en) 2015-12-14 2022-10-25 Societe Des Produits Nestle S.A. Nutritional compositions and infant formula for promoting de novo myealination
US12060573B2 (en) 2016-01-18 2024-08-13 Amorphical Ltd. Stabilized amorphous calcium carbonate as a supplement for cell culture media
KR20180109941A (ko) * 2016-01-18 2018-10-08 아모피컬 리미티드 신경, 근육 및 불임 질환 또는 병증의 치료를 위한 안정화된 무정형 탄산칼슘
AU2017349921B2 (en) * 2016-10-25 2023-06-15 Amorphical Ltd Amorphous calcium carbonate for treating a leukemia

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4237147A (en) 1974-01-04 1980-12-02 Monsanto Company Stabilized amorphous calcium carbonate
US4199496A (en) * 1974-09-05 1980-04-22 Johnson Edwin L Process for the recovery of chemicals from the shells of crustacea
US5886012A (en) * 1989-03-22 1999-03-23 Peter K. T. Pang Method of treatment for disease associated with excessive PHF using combination therapy involving exogenous calcium and calcium channel blockers
US20060165784A1 (en) * 1997-05-06 2006-07-27 Zhao Jin R Calcium supplement
US20030077604A1 (en) * 2000-10-27 2003-04-24 Yongming Sun Compositions and methods relating to breast specific genes and proteins
JP2002205947A (ja) * 2000-12-11 2002-07-23 Chafflose Corporation 水虫治療薬
EP1416916B1 (en) * 2001-08-16 2007-10-17 Cmp Therapeutics Limited Chitin microparticles and their medical uses
JP2004081739A (ja) * 2002-08-29 2004-03-18 Mitsuru Akashi ハイドロキシアパタイト−ポリマー複合材料の止血用組成物
EP1666046A4 (en) * 2003-09-17 2007-10-03 Univ Pla 3Rd Military Medical USE OF N-ACETYL-D-AMINOGLYCOSAMINE FOR THE PREPARATION OF DRUGS FOR THE TREATMENT OF CANCER AND METASTASES
EP1758599B1 (en) * 2004-05-26 2013-11-27 Ben Gurion University Of The Negev Research And Development Authority Orally-administrable compositions comprising stable amorphous calcium carbonate
US20070286886A1 (en) * 2004-10-15 2007-12-13 University Of Tennessee Research Foundation Materials And Methods For Inducing Apoptosis In Adipocytes

Also Published As

Publication number Publication date
CA2665141C (en) 2015-03-24
WO2008041236A3 (en) 2009-05-14
EP2068891A2 (en) 2009-06-17
WO2008041236A2 (en) 2008-04-10
US20130122117A1 (en) 2013-05-16
AU2007303786A1 (en) 2008-04-10
US20100098774A1 (en) 2010-04-22
IL178495A0 (en) 2007-02-11
ES2439741T3 (es) 2014-01-24
US8728533B2 (en) 2014-05-20
CY1114930T1 (el) 2016-12-14
CA2665141A1 (en) 2008-04-10
SI2068891T1 (sl) 2014-02-28
AU2007303786B2 (en) 2012-07-26
CN101563091A (zh) 2009-10-21
PL2068891T3 (pl) 2014-03-31
JP2010505818A (ja) 2010-02-25
EP2068891B1 (en) 2013-09-25
IL178495A (en) 2014-12-31
PT2068891E (pt) 2013-12-27

Similar Documents

Publication Publication Date Title
DK2068891T3 (da) Sammensætning omfattende krebsdyr gastrolith komponenter, calciumcarbonat og anvendelse deraf
FR22C1008I2 (fr) Composition immunogène
NO2022027I1 (no) Combination of daunorubicin and cytarabine
IL244442A0 (en) Compounds of converted acylanilides and their use
DK2069352T3 (da) Bestemte kemiske enheder, sammensætninger og fremgangsmåder
NO20085030L (no) Pyrrolopyrimidinforbindelser og deres anvendelser
DK2107905T3 (da) Fast sammensætning omfattende alogliptin og pioglitazon
DK2099823T4 (da) Målbindingsmiddelvarianter og anvendelser deraf
DK1948149T3 (da) Præparat indeholdende metformin og vildagliptin
DK1765327T3 (da) Forbindelser, sammensætninger og fremgangsmåder
DK1996557T3 (da) Pyridazinon-forbindelse og anvendelse deraf som herbicid
NO20055686D0 (no) Sammensetning
DK2185164T3 (da) Sammensætning og terapeutisk antitumorvaccine
DK1954140T3 (da) Glycerollevulinatketaler og deres anvendelse
DE602006015807D1 (de) Abgeschwächter dengue-serotyp-2-stamm
DK2079485T3 (da) Phenylpropionamidforbindelser og anvendelsen deraf
DK2001556T3 (da) Thioninium-forbindelser og anvendelse deraf
DK1937276T3 (da) Forbedret testosterongel og fremgangsmåde til anvendelse deraf
DK1976548T3 (da) VIP-fragmenter og sammensætninger deraf
DK2158281T3 (da) Farvepigmenteret laksammensætning med høj dækkeevne, forøget ridsefasthed, og let-at-rengøre egenskaber
FR2883132B1 (fr) Composition alimentaire suppletive
DE112007000221A5 (de) Abseilvorrichtung
DK2334596T3 (da) Ferriphosphatbaseret sammensætning og anvendelse heraf
FR2882894B1 (fr) Composition alimentaire suppletive
DE502006004891D1 (de) Agrochemische zusammensetzung